News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alkermes
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Alkermes Rockets as Depression Drug Aces Key Late-Stage Trial
October 21, 2016
·
2 min read
Pharm Country
How Alkermes Transformed an Anti-Addiction Drug From a Bust to a Hit
September 28, 2016
·
2 min read
Drug Development
Stock Craters as Alkermes’ Depression Drug Fails in Two Late-Stage Trials
January 21, 2016
·
3 min read
Job Trends
1,075 New Jobs to be Added by 11 Life Science Firms in Massachusetts: Amgen, Alnylam, Biogen Idec, Inc. (North Carolina), GE Healthcare Bio-Sciences, Quest Diagnostics, Alkermes, Baxter Healthcare, Merrimack, Synageva BioPharma, Philips Electronics, SMC
March 19, 2015
·
2 min read
Deals
Alkermes Dumps Georgia Facility, Pain Drug Rights to Recro Pharma in $170 Million+ Deal
March 9, 2015
·
2 min read
BioCapital
2015 Could Be Blockbuster Year for Alkermes plc, Says Citi
December 17, 2014
·
2 min read
Genetown
Alkermes plc CEO’s Take On Building Big, Playing Well With Pharma
April 21, 2014
·
1 min read
Pharm Country
How One Biotech Company, Alkermes plc, Survived A Brush With Death
November 11, 2013
·
1 min read
BioCapital
Exenatide Clinical Data Analysis Shows No Increased Risk Of Cardiovascular Events, Amylin Pharmaceuticals, Inc., Eli Lilly and Company And Alkermes Announce
March 27, 2009
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference
June 3, 2021
·
1 min read
FDA
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
June 1, 2021
·
19 min read
Business
Alkermes Announces the Appointment of Emily Peterson Alva to its Board of Directors
May 20, 2021
·
6 min read
Business
Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
May 13, 2021
·
2 min read
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference
May 5, 2021
·
1 min read
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
May 3, 2021
·
14 min read
Business
Alkermes Announces Agreement with Sarissa Capital
April 30, 2021
·
4 min read
Alkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual Meeting
April 28, 2021
·
3 min read
Business
Alkermes plc Reports First Quarter 2021 Financial Results
April 28, 2021
·
15 min read
Alkermes Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patients With Melanoma
April 27, 2021
·
6 min read
